Date: 2014-10-14
Type of information: Collaboration agreement
Compound: wearable diagnostic prototype
Company: Philips (The Netherlands) Dutch Radboud university medical center (The Netherlands)
Therapeutic area: Allergic diseases - Inflammatory diseases - Respiratory diseases
Type agreement: collaboration
Action mechanism:
Disease: chronic obstructive pulmonary disease (COPD)
Details: * On October 14, 2014, Philips and Nijmegen, the Netherlands-based Radboud university medical center (Radboudumc) announced the debut of a prototype to support patients with chronic obstructive pulmonary disease (COPD). The launch marks the start of joint explorations between Philips and Radboudumc to apply mobile, digital and cloud technologies to improve patient outcomes, care coordination and patient empowerment across the health continuum. The wearable diagnostic prototype for COPD patients feeds data collected from patients at home to clinicians through the Philips HealthSuite Digital Platform to two clinical applications currently available on the cloud-based platform – eCareCompanion and eCareCoordinator – which both recently received FDA 510(k) clearance. Once a COPD patient has left the hospital, a wearable diagnostic prototype collects data day and night – including physical activity/inactivity, respiratory indicator, heart rhythm and heart rate variability. That data is then sent via the cloud to the Philips HealthSuite Digital Platform, where it is shared with the appropriate care providers via the eCareCoordinator application, presenting a more complete view of the patient’s illness.
Financial terms:
Latest news:
